MORGAN FOSTER: Open Payments
NPI 1518675347 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 37 payments from 9 companies in 2025. Trend: 2023 $1,208 · 2024 $1,378 · 2025 $607
Food & beverage: $604Education: $4
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $167 |
| ABBVIE INC. | 14 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: VRAYLAR, LYBALVI, TRINTELLIX, Auvelity, ARISTADA, REXULTI, CAPLYTA, Jornay PM.
Industry payments across VA — which companies pay providers there.
